238 related articles for article (PubMed ID: 19865800)
1. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
2. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
[TBL] [Abstract][Full Text] [Related]
3. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization.
Scheil S; Brüderlein S; Eicker M; Herms J; Herold-Mende C; Steiner HH; Barth TF; Möller P
Brain Pathol; 2001 Apr; 11(2):133-43. PubMed ID: 11303789
[TBL] [Abstract][Full Text] [Related]
4. [Detection of chromosomal imbalance in ependymoma by comparative genomic hybridization].
Wu WX; Yu SZ; Sun CY; Wang Q; Jin SM; An TL
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):148-52. PubMed ID: 19575847
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal imbalances in clear cell ependymomas.
Rickert CH; Korshunov A; Paulus W
Mod Pathol; 2006 Jul; 19(7):958-62. PubMed ID: 16648869
[TBL] [Abstract][Full Text] [Related]
7. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
Carter M; Nicholson J; Ross F; Crolla J; Allibone R; Balaji V; Perry R; Walker D; Gilbertson R; Ellison DW
Br J Cancer; 2002 Mar; 86(6):929-39. PubMed ID: 11953826
[TBL] [Abstract][Full Text] [Related]
13. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G
J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655
[TBL] [Abstract][Full Text] [Related]
14. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
16. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
17. Chromosome DNA imbalances in human astrocytic tumors: a comparative genomic hybridization study of 63 Chinese patients.
Jin S; Sun C; Yu S; Wang Q; Wu W; Sun Y; Zhao W; An T
Pathol Res Pract; 2010 Oct; 206(10):674-81. PubMed ID: 20591577
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
19. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]